Correlation Between Syndax Pharmaceuticals and Inhibikase Therapeutics
Can any of the company-specific risk be diversified away by investing in both Syndax Pharmaceuticals and Inhibikase Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syndax Pharmaceuticals and Inhibikase Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Syndax Pharmaceuticals and Inhibikase Therapeutics, you can compare the effects of market volatilities on Syndax Pharmaceuticals and Inhibikase Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syndax Pharmaceuticals with a short position of Inhibikase Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syndax Pharmaceuticals and Inhibikase Therapeutics.
Diversification Opportunities for Syndax Pharmaceuticals and Inhibikase Therapeutics
-0.04 | Correlation Coefficient |
Good diversification
The 3 months correlation between Syndax and Inhibikase is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Syndax Pharmaceuticals and Inhibikase Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibikase Therapeutics and Syndax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syndax Pharmaceuticals are associated (or correlated) with Inhibikase Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibikase Therapeutics has no effect on the direction of Syndax Pharmaceuticals i.e., Syndax Pharmaceuticals and Inhibikase Therapeutics go up and down completely randomly.
Pair Corralation between Syndax Pharmaceuticals and Inhibikase Therapeutics
Given the investment horizon of 90 days Syndax Pharmaceuticals is expected to generate 21.02 times less return on investment than Inhibikase Therapeutics. But when comparing it to its historical volatility, Syndax Pharmaceuticals is 2.18 times less risky than Inhibikase Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Inhibikase Therapeutics is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 124.00 in Inhibikase Therapeutics on September 4, 2024 and sell it today you would earn a total of 152.00 from holding Inhibikase Therapeutics or generate 122.58% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Syndax Pharmaceuticals vs. Inhibikase Therapeutics
Performance |
| Timeline |
| Syndax Pharmaceuticals |
| Inhibikase Therapeutics |
Syndax Pharmaceuticals and Inhibikase Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Syndax Pharmaceuticals and Inhibikase Therapeutics
The main advantage of trading using opposite Syndax Pharmaceuticals and Inhibikase Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syndax Pharmaceuticals position performs unexpectedly, Inhibikase Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibikase Therapeutics will offset losses from the drop in Inhibikase Therapeutics' long position.| Syndax Pharmaceuticals vs. Cogent Biosciences | Syndax Pharmaceuticals vs. Cullinan Oncology LLC | Syndax Pharmaceuticals vs. Kalvista Pharmaceuticals | Syndax Pharmaceuticals vs. Mersana Therapeutics |
| Inhibikase Therapeutics vs. Candel Therapeutics | Inhibikase Therapeutics vs. Cingulate Warrants | Inhibikase Therapeutics vs. Unicycive Therapeutics | Inhibikase Therapeutics vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |